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Abstract
Effect of Insulin on the Regulation of NKCC Cotransporter 
(NKCC2) in HEK293 Cells
 Jin-Ill Lee, D.D.S., Ph.D. candidate
Department of Dentistry, The Graduate School,
 Yonsei University
(Directed by Prof. Syng-Ill Lee, D.D.S., Ph.D.)
Insulin is one of the regulators involved in Na+ reabsorption 
in kidney. The Na+ channel and Na/K/2Cl cotransporter (NKCC2) 
system are primarily considered as the possible routes for Na+ 
movement into the cell. The purpose of this study is to 
understand the regulation of NKCC2 as a candidate for Na+ 
movement across the kidney cell in response to insulin. In order 
to clarify the role of the insulin in human embryonic kidney cell 
line, HEK293, the cells were exposed to the different 
circumstances (isotonic, hypertonic), and then cell volume, 
expression of NKCC2 mRNA, intracellular Ca2+ and functional 
activity of the cotransporter using pH dye, and the intracellular 
Ca2+ level were analyzed in each condition. The cell volume of 
HEK293 which was shrunken by hypertonic stress recovered to 
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nearly original state by the addition of 1 μM insulin. It is 
obvious that insulin prevented cell shrinkage by operating the 
regulatory volume increase (RVI) machinery of the cell. However, 
insulin-induced RVI was blocked by the treatment of 10 μM 
bumetanide. Furthermore, NKCC2 mRNA was expressed 
remarkably in the presence of 1 μM insulin. Such results might 
suggest that the volume regulation of HEK293 cell was, at least, 
in part mediated through bumetanide sensitive NKCC. On the 
other hand, the HEK293 cell showed the typical change in 
intracellular Ca2+ concentration in response to carbachol as seen 
in other normal cells. However, insulin did not induce the change 
of intracellular calcium level of the HEK293 cell. Taken all 
together, these findings suggest that the insulin stimulates the 
sodium transport of HEK293 cell through the upregulation of 
NKCC2 under the hypertonic condition. 
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
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I. Introduction
The first step of urine processing starts in Bowmanns 
capsule, the functional unit of nephron. Virtually all plasma 
except proteins passively filter into glomerular tubule. Then most 
of the ion is reabsorbed into blood. Defonso et.al. (1976) 
reported that insulin promoted Na+ reabsorption in the above 
mentioned process. Naturally, question arises about the route of 
this insulin mediated increase in Na+ reapsortion. The possible 
candidate machinery for the effects are Na+-glucose cotransporter 
and Na/K/2Cl cotransporter (NKCC). Type one of NKCC is 
found in almost all kinds of cell but type II of NKCC is found 
exclusively in Kidney. Of the two candidates mentioned above, 
Na-glucose cotransporter reabsorbs sodium with glucose from 
basolateral side into blood side in proximal tubule. NKCC 
reabsorbs sodium with chloride and potassium in an electrically 
silent way. 
Among the cell membrane proteins, NKCC is found in both 
secretory and non-secretory epithelia. Although NKCC is known 
to mediate the transmembrane movements of Na+, K+, and Cl-, its 
function is different depending on types of cell (O' Grady, 1987; 
Haas, 1989; Geck et. al., 1980; Breitwieser et al., 1990; Turner 
et. al., 1993). For example, the cotransporter contributes to 
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regulation of salt and water in excitatory tissues, red blood cell 
and most of the cultured cells. On the other hand, NKCC2 is 
used mainly to import Cl- in Cl- secretory or Cl- absorptive 
epithelia. In addition to NKCC2, Cl- channel, K+ channel and 
Na+/K+ pump is known to be closely inter-related in intracellular 
Cl- movement (Silva et. al., 1977). Cl- movement via NKCC2 has 
been reported in kidney and rectum. The NKCC2 is essential in 
NaCl secretion in avian salt gland (O'Grady et. al., 1987). 
Likewise, the NKCC is crucial in salivary secretion in that it 
regulates salt movements and obliged fluid absorption and 
secretion. Besides, it is important in salt absorption in kidney and 
maintenance of intracellular Cl- ion concentration in nerve cell. 
As mentioned above, understanding about the cotransporter and its 
regulation mechanism is essential for studying signal transduction 
system (Turner et. al., 1986; Haas, 1994; Payne and Horbush, 
1995).
As it has been mentioned, each transport cycle of NKCC is 
electrically silent. Which means that the sum of the cation 
crossing the membrane is same as the sum of the chloride ions 
crossing the membrane. The transport stoichiometry is 1Na/1K/2Cl 
in most cells. As all three ions are used, the lack of any of the 
three cotransported ions leads to down regulation of the 
cotransporter (O'Grady et. al., 1987; Haas, 1989; Geck and Heinz, 
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1986).
Several studies have shown that the location of cotransporter 
and its sensitivity to furosemide (a kind of loop diuretics), differs 
among tissue types. The secretory NKCC1 cotransporter is located 
at basolateral side, whereas the absorptive one is located on 
apical side of the cell membrane. The cloning of cDNA of 5260 
bp by Xu et al. (1994) gave a breakthrough in the study of the 
cotransporter (Xu et. al., 1994).  Based on such studies, Xu et 
al. suggested that there are 1191 amino acids with 12 
transmembrane domains having both N- and C-terminal inside the 
cell. When this cDNA was transfected into human embroyonic 
kidney cell line (HEK293), there was ten fold increase in [86Rb+]i 
which is dependent on Na+ and Cl-. Northern blot analysis 
showed 7.4 kb mRNA, which was found also in brain, colon, 
heart, liver and rectal gland (NKCC1). A 5.2kb mRNA was 
found exclusively in kidney and named NKCC2 by Payne et al. 
(1994).
The activation mechanism of the cotransporter is not revealed 
clearly as yet.  It can be said that at least the actin cytoskeleton 
is involved in activation of NKCC (Matthews et. al., 1992; 
Matthews et. al., 1994; Payne et. al., 1995; Wu et. al., 1994). In 
addition to volume change, other factors have been known to 
affect the control of the cotransporter. Then what kind of factor 
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activates NKCC and how it is regulated? It has been found that 
cAMP or hormones that activate protein kinase C (PKC) and 
protein phosphatases (Lytle and Forbush, 1992; Pewitt, 1990a, b; 
Leung et. al., 1994; Paulais and Turner, 1992; Palfrey and Pewitt, 
1993; Klein and O'Neill, 1993) influence activation of the 
cotransporter. There are several reports showing that stimuli that 
provoked the increase in the cotransporter activity also increased 
phosphorylation of the cotransporter. In the study using nasal 
mucosal culture cell from the patient of cystic fibrosis (the cells 
of a patient with cystic fibrosis is defective of Cl- channel which 
is activated by cAMP), it was found that though there was not 
cyclic AMP mediated Cl- channel, purinergic receptor mediated 
Cl- channel and NKCC was found. 
Recently, the phosphorylation site by PKA has been found in 
human colon NKCC and the regulation mechanism by direct 
phosphorylation/activation has been suggested at least in human 
(Payne et. al., 1995; Payne and Forbush, 1994). The activation of 
the cotransporter by phosphrylation- dephosphorylation has been 
proposed at first by Altamirano et al. (1988). According to their 
report, when giant squid axon pre-treated with vanadate or 
fluoride (both are phosphatase inhibitor) was suspended in ATP 
free medium, the activation of NKCC was extended. As more 
direct evidence, the phosphorylation itself regulated the 
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cotransporter activity (Altamirano, 1988).
Since it has been found that if the Cl- channel at the apical 
membrane of the rectal gland tubule is blocked, the 
phosphorylation of the NKCC also was decreased, the secondary 
modulation by the cotransporter has been suggested (Lytle and 
Forbush, 1992). It means that it is not certain if the activation of 
cAMP of the NKCC is the result of direct activation of 
cAMP-dependent protein kinase (PKA) or that of other secondary 
kinase. Lytle and Forbush (1992) suggested that phosphorylation 
of rectal gland cotransporter by secretagogues is rather an indirect 
result of change in intracellular chloride concentration, than a 
direct effect of PKA. These Cl-coupling hypothesis is supported 
by the fact that there is not a PKA phosphorylation site in 
sNKCC1 (Xu et. al., 1994). In addition, the experiment with 
rectal gland tubule incubated in elevated K+ concentration showed 
that when Cl- relaease through apical membrane were blocked, 
there was not phosphorylation of the cotransporter by forskolin. 
Thus, phosphorylation of NKCC is closly interrelated with Cl-. 
However there are differences in interpreting the activation 
mechanism of the cotransporter. One group suggests that once Cl- 
channel is activated, cell shrinkage is followed by the low 
intracellular Cl- ion concentration. Thus in order to restore cell 
volume, the NKCC is directly phosphorylated. Others suggest that 
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decreased Cl- concentration itself directly activates the 
cotransporter. On this aspect, primary concern has been given to 
the transport process of the extracellular Cl- and its modulation, 
in Cl- secreting gland cells.
Diabetes, which is commonly involved with insulin, can be 
divided into two types. Type one is insulin independent and 
occurs about 5 to 10 percent of patients. Remaining 95 to 90 
percent of diabetes patients fall into type II, recently known to 
be involved with resistin (Steppan, 2001). In dental diseases, 
diabetes complicate wound healing and control of periodontal 
disease. Insulin has various effects in human body. Besides the 
effect on ion transport, which is the main concern of this study, 
it has metabolic effects including metabolism of carbohydrates, 
protein and lipids and growth promoting effects on DNA 
synthesis and cell division. It's action is initiated in membrane 
receptor, followed by increase in tyrosine kinase activity of β
-subunit and autophosphorylation, resulting in sequential 
phosphorylation or dephosphorylation of other inctracellular 
proteins. As it is well known that increase in intracellular Ca2+ is 
crucial in activation of the NKCC2, there is the possibility that 
insulin can influence in activation of the cotransporter in HEK293 
cell. In regards to diseases, the role of the cotransporter in 
relation to the cell volume has been limited in hypertension. 
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However, as the clinical report says, from 50% to 70% of 
diabetes patients finally suffers from kidney disease. Thus the role 
of the cotransporter in kidney should not be overlooked and we 
hope that if the present study should help in revealing the role of 
the cotransporter, it will provide important data for the 
relationship between diabetes and NKCC2.
In the present study, we observed how cotransporter is 
regulated by insulin in HEK293 cell. It is based on the 
hypothesis that insulin effect on Na+ reapsortion is mainly due to 
NKCC2 activity. Thus we focused on NKCC2 and recorded the 
change of its activity. The cells were exposed to normal and 
hypertonic condition, observed expression of NKCC2 mRNA, 
intracellular Ca2+ and functional activity of the cotransporter using 
pH dye in each condition to find out 1) the effect of cell volume 
in activation of the cotransporter, 2) expression of NKCC2 
mRNA, and 3) how insulin makes effects on expression of 
NKCC2 and its fuctional activity on cell volume.
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Ⅱ. Materials and methods
1. Materials
All routine cell culture media were obtained from 
GIBCO/BRL (Grand Island, NY). Insulin was purchased from 
Sigma Chemical Co., Ltd. (St. Louis, MO). ICR mice were 
purchased from Samtacho Co., Ltd. (Seoul, Korea). All other 
chemicals were of the highest grade commercially available.
2. Methods
Of the two regulation mechanism of NKCC2 (metabolic and 
non-metabolic), we expected cell volume change by metabolic 
regulation. These volume change is one of the controlling factor 
regulating cell function. It also is involved in protein synthesis 
and degradation and is known to affect gene, enzyme, carrier and 
messenger. We therefore expected change in mRNA expression of 
HEK293 cell after stimulating with insulin. In the present study 
we examined how insulin works on the transporting system which 
is widely used for control of diabetes.
(1) HEK293 cell cuture
Human Embryonic Kidney cells (HEK293) (ATCC, 
Manassas, VA) which were stored at -86 ℃ were released in 37 
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℃ water bath, incubated in 10 ml culture media (DMEM, 
penicillin-streptomycin, Newborn calf serum, L-glutamine), and 
then dispersed by forcing through polypropylene pipettes with 
decreasing orifice. Then the cells were centrifuged at 1000 rpm 
for 10 minutes. After removing the supernatants, the cells were 
prepared for culture dish and cultured in 37 ℃, 100% humidity, 
5% CO2. Culture media was changed every 3 day, and carefully 
managed to grow cell in monolayer
(2) Measurement of cell volume
The coverslip on which cell were cultured was mounted on 
a chamber, which was set on the mechanical stage of an inverted 
microscope connected to a video-imaging system. The cells were 
perfused with insulin-containing solution for 10 min before the 
experiments. Images of the cell through optical microscope were 
continuously recorded with a video image system. To estimate 
cell volume, the area of the HEK293 cell in the video image 
was measured.
(3) Measurement of intracellular pH and Ca2+ concentration
In order to stimulate the cell and obtain the cellular 
responses, perfusion system was used. HEK293 cells were loaded 
with fura-2 by incubation with 2 μM fura-2/AM in 
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HEPES-buffered solutin (mM; NaCl 110, KCl 4.5, NaH2PO4 1.0, 
MgSO4 1.0, CaCl2 1.5, NaHCO3 25, HEPES-Na 5, HEPES free 
acid 5, D-glucose 10; equilibrated with 95% O2, 5% CO2 to give 
a pH of 7.4). The cells were allowed to attach to a coverslip 
which formed the base of a cell chamber mounted on the stage 
of inverted microscope (Nikon, Japan), and [Ca2+]i was measured 
in single cells by spectrofluorometer (Photon Technology 
International, Brunswick, NJ, USA) with excitation at 340 nm and 
emission measured at 510 nm (Fig. 1). The measured values 
represent as a ratio of 340/510.
The cells were perfused at the flow rate of 2 ml/min with 
perfusion pump (Micro Tube Pump, MP-3) during the pH and 
intracellular [Ca2+]i were measured. The pH and intracellular 
[Ca2+]i were recorded continously using the personal computer. To 
keep the temperature 37 ℃, perfusion system was equipped with 
water jacket.
(4) Preparation of perfusion solution
The functional activity of NKCC2 was measured. The 
composition of perfusion solution was shown in Table 1.  NH4+ 
pulse (20 mM) was challenged to give a alkaline shock to the 
cell. In the case of alkaline shock (20 mM NH4Cl), 20 mM 
NaCl was removed instead of adding 20 mM NH4Cl, to keep the 
- 13 -
Fig. 1. Schematic diagram of Spectrofluorometer for the 
mesurement of intracellular pH and Ca2+.
- 14 -
Table 1.  Composition of perfusion solution (mM)
pH Ca2+ High K+ solution
NaCl
KCl
NaH2PO4
MgSO4
CaCl2
HEPES-Na
HEPES
NaHCO3
D-Glucose
127.5
4.5
1.0
1.0
1.5
10.0
10.0
0.0
10.0
110.0
4.5
1.0
1.0
1.5
5.0
5.0
25.0
10.0
0.0
132.0
1.0
1.0
0.0
10.0
10.0
0.0
10.0
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osmolarity to the physiological condition. While test was 
performed in Ca2+ free solution, making nominally zero Ca2+ by 
adding 1 mM EGTA.  Perfusion solution was kept at 37 ℃ in 
water bath.
(5) hNKCC2 mRNA expression
RNA extraction, quantitation, and RT-PCR was executed by 
the method described in Sambrook et al. (1989) with slight 
modification.
① Extraction of total RNA
Insulin was treated into the culture dish. in which cell grows 
in the form of monolayer. Response to the insulin was checked 
as a function of time and doses. For isolation of RNA from 
HEK293 stimulated by insulin, cells were lysed using Trizol. That 
is,  after the completion of the reaction by insulin for the given 
period of time, medium was discarded followed by two times 
washing for elimination of remaining PBS. One ml of Trizol was 
mixed with  the cells, and passing the cell lysates several times 
through the pipette. Another 1 ml of Trizol added to the 
pretreated cells to make them completely solubilized. A Trizol 
treated cells were kept in room temperature for 5 min, and mix 
it thoroughly with same volume of chloroform, then stand it on 
- 16 -
the bench for another 3 min. Spin it at 12,000×g for 15 min, 
take the supernatant and move the sample to the new tubes and 
add the same volume of isopropanol, allowing 10 min reaction on 
the bench for 10 min. It was spinned at 12,000×g and the pellet 
was suspended in 1 ml of 75 % ethanol. The final suspended 
pellets were stored in at -70 ℃ until next experiment. All plastic 
and glassware was autoclaved, all buffers were made RNAase 
free by treatment with 0.05 % DEPC or purchased RNAase free.
② RNA quantitation and visualization
Aliquot in 75% ethanol was centrifuged at 15,000 rpm for 5 
min. And extracted RNA was dissolved in 50 ㎕ DPEC water. 
RNA concentration was measured by UV Spectrophotometry at 
260 nm. RNA quantity was quantitated in ìg/ml.
③ cDNA synthesis and RT-PCR 
One ㎍ of total RNA was taken and samples for PCR were 
mixed with 1 ㎕ of oligo (dT) 18 primer and made up to 12.5 
㎕ with sterile water treated with DEPC. Mixtures were heated at 
70¡℃ for 5 min. and cooled down. After snap centrifugation    
Reaction buffer, dNTP mix, recombinant RNase inhibitor, MLV 
reverse transcriptase were added. Mixture were incubated at 42 ℃ 
for 1 h and 94 ℃ for 5 min to stop the synthesis of cDNA. 
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cDNA synthesized placed on ice for immediate use, or stored at 
-20¡℃.
④ Polymerase chain reaction (RT-PCR) and electrophoresis
Oligonucleotide primers were synthesized by gene tech PCR 
amplification was performed in a thermal cycler on 2 ㎕ of 
cDNA in a reaction volume of 30 ㎕ containing 2 mM MgCl2, 
200 μM each deoxynucleoside triphosphate, 0.2 μM each 
primer. Amplification was carried out using 29 cycles of 94 ℃ 
for 5 min. When the reaction mixture was reached up to 80 ℃, 
ampli-Tag enzyme was added, followed by another reaction at 94 
℃ for 30 sec, 63 ℃ for 30 sec, and 72 ℃ 1 min. Again, DNA 
extension was done reacting at 72 ℃ for 7 min. The synthetic 
cDNA, buffer, dNTP, MgCl2, primers (upper primer : 5'-GCA 
TTT GAT TTT GAG ATT GGC GTG GTT-3', lower primer ; 
5'-TTT GGC CTA ATG TTG ATG TCA CCG ATG ATA-3') put 
in the PCR tube, and then was reacted at 94 ℃ for 5 min.
Following amplification, PCR products were visualized by 
electrophoresis on 1.5% agarose gels with TBE buffer at 120 
volts. A 100 bp ladder was also loaded to allow size estimation.
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Ⅲ. Results
1. Volume response of HEK293 to insulin or hypertonic 
condition
For the preliminary examination, HEK293 cell was treated 
with insulin and cellular volume change was observed. When the 
medium containing 1 μM of insulin perfused to HEK293cell, no 
significant volume change was detected. Cellular volume response 
of HEK293 cell to hypertonic condition was also observed by 
perfusing the medium containing 100 mM of sucrose. As shown 
in Fig. 2 more than 30 % of the cell volume was decreased 
when HEK293 cell was perfused with 100 mM of sucrose 
solution in perfusion chamber. When the sucrose solution was 
substituted with normal medium, HEK293 cell restored its volume 
after short period of cell shrinkage. 
2. Effect of insulin on the regulation of cell volume in 
HEK293 under hypertonic condition
The effect of insulin on volume regulation of HEK293 cell 
under hypertonic condition was tested (Fig. 3). Since no 
significant effect of insulin on cell volume was detected in 
isotonic condition, the experiment was carried out in hypertonic 
condition.  As shown in Fig. 2, When the hypertonic stress using 
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Fig. 2. Volume change of HEK293 cell in hypertonic condition.
The medium containing 100 mM of sucrose was perfused to 
the chamber which HEK293 cell was mounted. After 30 minutes 
perfusion, the medium was substituted to normal medium. Cell 
volume change of HEK293 cell was measured by computerized 
video-imaging system. The images of the optical microscope were 
continuously recorded. To estimate cell volume, the area of 
HEK293 cell in the video image was measured. The averaged 
value of area measured in the first 2 min was used as the 
control. The relative cell volume, V/V0 was estimated, where V 
is the volume, and subscript 0 is the value of the control.
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Fig. 3. Effect of insulin on volume change of HEK293 cell in 
hypertonic condition.
The medium containing 100 mM of sucrose was perfused to 
the chamber which HEK293 cell was mounted. After 10 minutes 
perfusion, the medium was substituted to the medium containing 
sucrose and insulin. Cell volume change of HEK293 cell was 
measured by computerized video-imaging system. The images of 
the optical microscope were continuously recorded. To estimate 
cell volume, the area of HEK293 cell in the video image was 
measured. The averaged value of area measured in the first 2 
min was used as the control. The relative cell volume, V/V0 was 
estimated, where V is the volume, and subscript 0 is the value of 
the control.
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sucrose containing medium was applied to HEK293 cell, cellular 
shrinkage was initiated the same manner. After 10 minutes 
perfusion of hypertonic medium which contains 100 mM sucrose, 
1 μM of insulin was added to the hypertonic medium. As 
insulin containing hypertonic medium was perfused, the volume 
was recovered to original state. It can be inferred from this result 
that insulin activated regulatory volume control mechanism of 
HEK293 cell.
3. Involvement of NKCC2 in regulatory volume increase in 
HEK293 cell
Since the regulatory volume increase was activated by 
insulin, it is necessary to identify the main route which insulin 
may activate the regulatory volume increase. To identify the 
mechanism bumetanide, which is a specific inhibitor of NKCC, 
was used. HEK293 cell was applied to hypertonic condition to 
induce hypertonic shrinkage (Fig. 4). After 20 minutes perfusion 
of hypertonic medium, 1 μM of insulin and 10 μM of 
bumetanide were added to the hypertonic medium simultaneously. 
As shown in Fig. 2, the addition of insulin triggered the recovery 
of cellular volume in HEK293 cell to the resting stage. However, 
when insulin and bumetanide was added simultaneously to the 
hypertonic medium, such recovery was not detected and the 
- 22 -
Fig. 4. Volume response of HEK293 cell to insulin and 
bumetanide in hypertonic condition.
The medium containing 100 mM of sucrose was perfused for 20 
minutes to the chamber which HEK293 cell was mounted. The 
medium was then substituted to the medium containing sucrose, 
insulin and 10 μM of bumetanide and perfused for 40 minutes. 
Normal medium was perfused to the chamber for the last 20 
minutes to confirm the recovery of cell volume. Cell volume 
change of HEK293 cell was measured by computerized 
video-imaging system. The images of the optical microscope were 
continuously recorded. To estimate cell volume, the area of 
HEK293 cell in the video image was measured. The averaged 
value of area measured in the first 2 min was used as the 
control. The relative cell volume, V/V0 was estimated, where V 
is the volume, and subscript 0 is the value of the control.
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shrinkage of HEK293 cell maintained. The volume of HEK293 
cell was recovered to the resting stage when normal medium was 
perfused the chamber.
4. Activation of NKCC2 by insulin in hypertonic condition
In order to elucidate the effect of insulin on functional 
activity of NKCC2, pH recovery rate was measured. For this 
experiment NH4Cl was added to the medium and perfused to 
HEK293 cell. As NH4Cl containing medium perfused to the 
chamber intracellular pH [pH]i was rapidly increased. However 
the intracellular pH was slowly decreased (Table 2). After the 
medium was substituted to normal medium, the [pH]i was 
recovered to the resting stage. This experiment was repeated after 
5 minutes perfusion of insulin containing medium. When insulin 
containing medium was pre-perfused to the HEK293 cell, the 
decrease of intracellular pH which was increased due to the 
NH4Cl perfusion was slightly faster. This result indicates that 
pre-incubation of HEK293 cell in insulin containing medium 
might activate NKCC2 activity to recover the intracellular pH.
5. Increase of NKCC2 mRNA expression by insulin
To confirm the fact that insulin has direct effect on NKCC2, 
mRNA expression of NKCC2 was analyzed with RT-PCR. As the 
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Table 2. Effects of insulin on the pH recovery in hypertonic 
conditions.
Control
Insulin
Isotonic Hypertonic
Rate of pH 
recovery
- 3.38 ± 1.10 - 2.49 ± 0.35* - 4.05 ± 1.36
*: Significant difference between control and insulin treated group (p = 
0.00827). Each figures represent the mean ± standard error. Rate of pH 
recovery were measured to compare the activity of cotransporter, NKCC2 
before and after the treatment of insulin in condition of hypotonic and 
hypertonic condition. Insulin was added to the HEK 293 cell line for 30 min.  
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concentration of insulin was increased in isotonic condition the 
expression of NKCC2 mRNA in HEK293 cell was up regulated 
till 1 μM of concentration and slightly decreased at 10 μM 
(Fig. 5). This experiment was repeated in hypertonic condition 
using 100 mM sucrose. When 1 μM of insulin was added to 
the hypertonic medium, the expression of NKCC2 mRNA was up 
regulated as the same manner as in isotonic condition (Fig. 6).
6. Effect of insulin on intracellular Ca2+ concentration
Intracellular Ca2+ concentration in HEK293 measured using 
Fura-2. First of all, the response of HEK293 cell to carbachol, 
one of muscarinic effecters, was recorded. As shown in Fig. 7, 
typical biphasic pattern of Ca2+ change was appeared. The 
HEK293 cell showed the typical change in intracellular Ca2+ 
concentration in response to carbachol as seen in other normal 
cells, validating the cell and Ca2+ measuring system. The effect of 
insulin and response to cell volume change was measured and 
analyzed. As a result, Insulin did not change intracellular calcium 
level on the HEK293 cell. The change in cell volume (hypotonic 
or hypertonic condition) did not affect intracellular Ca2+ level. 
These results mean that the mRNA expression change by insulin 
was not mediated by increase in intracellular Ca2+. On the other 
hand, there is a report that there was increase in NKCC 
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Fig. 5. Effect of insulin on NKCC2 mRNA expression 
HEK293cell in isotonic condition. Insulin (1 μM) was added to 
the HEK293 cell culture. After incubation for additional 30 
minutes, total RNA was isolated. mRNAs were amplified 
according to the method described in materials and methods.
- 27 -
Fig. 6. Effect of insulin on NKCC2 mRNA expression 
HEK293cell in hypertonic condition. Insulin (1 μM) was added 
to the HEK293 cell culture in the presence of 100 mM sucrose. 
After incubation for additional 30 minutes, total RNA was 
isolated. mRNAs were amplified according to the method 
described in materials and methods.
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Fig. 7. Effect of insulin on the activity of Ca2+ channel of 
HEK293 cell. Carbachol (10 μM) was perfused to the chamber 
which HEK293 cell was mounted. The medium was then 
substituted to the medium containing insulin. Relative fluorescence 
was recorded using 340 and 380 nm fluorescence filters.
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cotransporter activity of NIH3T3 fibroblast in response to 
stimulation by bradykinin and PKC was involved in the signal 
transduction process (Sargeant et. al., 1995; Hichami et. al., 
1996). Possibly, there might be a difference in signal transduction 
system between HEK293 cell and fibroblast.
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Ⅳ. Discussion
In this study, we have observed the relationship between 
cotransporter and insulin in HEK293 cell. In physiological 
condition, renal tubules are exposed to dynamic osmotic 
environment, ranging from 300 to 1200 mOsmol. Especially, in 
Henly's loop, which is the part thought to be responsible for 
NKCC2 activation, osmotic environment is quite hypertonic. One 
of the main functions of NKCC2 is cell volume homeostasis. The 
physiological role of NKCC2 in volume control has been studied 
as part of the function of the cotransporter. In hypertonic 
condition, as cell volume is decreased, cell tries to recover its 
original volume by importing ions such as Na+/Cl-, so called 
regulatory volume increase (O' Grady, 1987; Haas, 1989). Na+/K+ 
cotransporter, Na+/H+ pump and Cl-/HCO3- exchanger also 
contribute to the process. Thus the volume change can be used 
as a parameter for NKCC2 activity. So we indirectly measured 
NKCC2 activity by recording volume change. The cells exposed 
to 100 mM sucrose showed hypertonic shrinkage and the addition 
of insulin activated regulatory volume increase (RVI) as shown in 
Fig. 2. There might be several candidates, which turn on the 
regulatory volume increase of HEK293 cells such as NKCC and 
Ca2+ channels. Among these, we have demonstrated the 
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involvement of NKCC2 in RVI that is induced by insulin. Fig. 3 
showed that bumetanide, which is a specific inhibitor of NKCC, 
showed inhibitory effect on RVI which was induced by insulin. 
The result clearly indicates that NKCC2 is the main route of 
insulin mediated regulatory volume increase in HEK293 cells.
Although there are evidences that NKCC in endothelial cells 
is activated by intracellular calcium and is inhibited by protein 
kinases (Klein, and O'Neill, 1993), the mechanism by which cell 
shrinkage activates cotransporter in a variety of cells is unknown. 
Breitweiser et al. (1990) reported that NKCC activity is 
dependent on intracellular Cl- concentration. In his experiment 
using squid giant axon (Breitwieser et. al., 1990; Hass and 
Mcbrayer, 1994). They also found that colonic cotransporter is 
directly activated by PKA (Molony et. al., 1987). At present, not 
all workers agree that NKCC activity is affected by intracellular 
chloride concentration. Nevertheless, it must be very interesting 
hypothesis that NKCC is secondarily activated as intracellular Cl- 
concentration is decreased, since it may contribute to 
understanding about the controlling mechanism about the import 
and export of Cl- in salt mobilizing epithelial cell. At present, it 
can be clearly said that as the cell shrinks as a result of the 
decreased intracellular Cl- concentration, this decreased cell 
volume may act as a secondary activator of the cotransporter 
- 32 -
(Payne and Horbush, 1995). Though it has not been clearly found 
how intracellular Cl- concentration modulate NKCC, a suggestion 
that Cl- binding site might be Cl- sensitive kinase (or 
phosphatase) or cotransporter itself.
Aside from the above mentioned studies on secretive type 
cotransporter, studies about the regulation of cotransporter activity 
on absorptive type cotransporter (NKCC2) has been done in 
mouse medullary thick ascending limbs of Henles loop (Sun et. 
al., 1991; Molony et. al., 1987). On such tissues, NaCl is 
re-apsorbed as Cl- is transported by cotransporter. And the 
cotransporter is activated by substances that activates cAMP, like 
ADH (antidiuretic hormone) (Molony et. al., 1987). Interestingly, 
a report by Sun et al. (1991) showed that chloride importation is 
done by Na+/Cl- cotransporter independent of K+ under 
unstimulated condition, whereas Cl- import was dependent upon 
K+ under stimulation with ADH (Sun et. al., 1991; Alvo et. al., 
1985; Schlatter and Greger, 1985). 
It has been suggested that forskolin reorganizes F-actin, and 
subsequent structural change in F-actin contributes to the 
incorporation of cotransporter in vesicular compartment (Molony 
et. al., 1987 Gamba, et. al., 1994; Shapiro, et. al., 1991). As has 
been iterated, NKCC is involved in cell volume regulation as 
well as Cl- resorption. On some types of cell, cAMP, intracellular 
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Ca2+ concentration or increase of protein kinase C activity 
contributed to the activation of cotransporter, while on other cell 
types, non or reverse effect by the same agents was reported 
(Paulais, and Turner, 1992). 
The mechanism of insulin action on cell volume regulation 
is not known much as yet. Nevertheless, there were reports that 
insulin activates both Na+-permeable channels (Marunaka, 1996) 
and the bumetanide-sensitive NKCC (Sargeant et. al., 1995), such 
activation would likely result in an increase in cell volume. To 
find out the mechanism of volume regulatory action of insulin 
under hypertonic condition, we tested the effect of bumetanide on 
the insulin-induced swelling. In order to elucidate the mechanism 
how insulin triggers NKCC2, the functional activity of NKCC2 
and mRNA expression were measured. After co-application of 
insulin and bumetanide, the HEK293 cell failed to recover its 
volume. Bumetanide blocked the insulin effect on volume 
recovery as seen above in Fig 2 almost completely. So we 
suggest that at least part of the action of insulin on HEK293 cell 
volume was mediated through bumetanide sensitive NKCC. When 
HEK293 cell was pre-perfused by insulin-containing medium, the 
decrease of intracellular pH that was increased due to the NH4Cl 
perfusion was slightly faster than the case of NH4Cl only. This 
result indicates that pre-incubation of HEK293 cell in insulin 
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might activate NKCC2 activity to recover the intracellular pH. 
It has been found that NaCl re-absorption increased by the 
mediation of cyclic AMP. Moreover, decrease in intracellular Cl-, 
ADH (increases cAMP), glucagon and isoproterenol are the factor 
that leads to the activation of the cotransporter and adds to the 
complexity of its regulation mechanism (Mattews et. al., 1992; 
Igarashi et. al., 1995; Russel et. al., 1990). The activation 
mechanism of the cotransporter, from what has been found so far, 
can be summerised as 1) direct phosphorylation of the 
cotransporter, 2) secondary regulation effect mediating Cl- channel, 
and 3) regulation through cytoskeleton. But, increase in membrane 
insertion of the cotransporter in cytosol can not be ignored 
because, 1) when parotid salivary acini of white mouse was 
stimulated with ALF4 (b-adrenergic agonist), phosphrylation of 
175 kD coransporter was closely related to the upregulation 2) 
whereas, in hypertonic shrinkage or treatment with calyculin A 
(phosphatase inhibitor) lead to upregulation without 
phosphorylation of the cotransporter, and 3) whereas carbachol (a 
kind of muscarinic agonist) induced upregulation of cotransporter 
accompanied phosphorylation, thapsigargin did not, even though it 
also mobilizes intracellular Ca2+ like carbachol. As it has been 
reviewed, upregulation of the cotransporter and phosphorylation of 
it needs not necessarily occur at the same time (Tanimura et. al., 
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1995). In other words, direct phosphorylation of the NKCC is 
only a part of the regulation mechanism. Then, 1) the possibility 
of activation through phosphorylation of membrane related protein 
other than direct phosphorylation of the transporter, 2) increase in 
membrane insertion of cotransporter in cytosol should be included 
in the activation process of the cotransporter.
In concern with the expression of mRNA expression insulin 
has up-regulated in both isotonic and hypertonic conditions. Under 
the isotonic condition, insulin increased the NKCC2 mRNA 
expression though the magnitude was different. On the other 
hand, the effect of insulin under hypertonic and isotonic condition 
was different. Insulin induced the expression of NKCC2 mRNA 
in bothe isotonic and hypertonic condition, however, physiological 
activity was activated in only hypertonic condition. Therefore, 
insulin might be considered as an activator of NKCC2 as well as 
inducer that can increase the expression of NKCC2 mRNA.
In conclusion, though NKCC2 is believed to be involved in 
cell volume regulation, essentially the cotransporter is involved in 
both physiologic volume regulatory and volume-sensitive transport 
mechanism. Insulin clearly increased NKCC2 mRNA expression 
when cell was shrunken. From the fact that insulin did not 
mobilize intracellular Ca2+, it was confirmed that Ca2+ was not 
involved in the expression of NKCC2 mRNA gene expression. As 
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mentioned above, insulin stimulates the sodium transport of 
HEK293 cells through the upregulation of NKCC2 under the 
hypertonic condition. 
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국문요약
Effect of Insulin on the Regulation of Na/K/Cl Cotransporter 
(NKCC2) in HEK293 Cells
연세대학교 대학원 치의학과
이진일
본 연구는 Kidney 세포주인 HEK293 세포에서 인슐린이 sodium 
재흡수에 미치는 영향을 살펴보고, 그 기전으로서 NKCC2에 의해 
ion transport 가 upregulation 되었을 가능성에 대해 기능적, 유전학적  
조사를 수행하였다.
신장에서 인슐린에 의한 Na+ reabsorption 증가에 대한 보고서가 
있는바 그 가능한 기전은 proximal tubule에 존재하는 Na-glucose 
cotransporter 와 Thick ascending loop of Henry 에 존재하는 NKCC2
를 들 수 있으며 본 연구에서는 insulin에 의한 효과가 주로 NKCC2
에 의한 것이라는 가설을 세우고 여러 조건에서 insulin에 의한 
NKCC2 activity 의 변화를 측정하였다.
세포용적 변화를 통한 실험에서 insulin은 고장액 상태에서 세포
용적 회복을 촉진시켰으며 bumetanide를 통한 실험으로 이런 효과가 
NKCC2 에 의한 것임을 확인하였다. 또한 세포에 insulin을 투여한 
후 alkaline shock을 부여하고 spectrophotommeter 를 통하여 pH 회복
율을 측정한 결과 고장액에서 recovery rate가 증가하는 경향을 확인
하였다.
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위에서의 결과를 토대로 유전자 수준에서 이를 확인하기 위해서 
각기 다른 농도의 insulin으로 전처리 후 mRNA의 변화를 관찰한 결
과 대조군에 비해 뚜렷한 mRNA expression의 증가를 확인하였다.
Insulin을 1 μM 로 고정하고 전처리 시간을 달리하여 mRNA의 
발현을 확인한 결과 10 분 경에는 약 5배 이상 증가한 것을 관찰하
였다. 이는 insulin response가 비교적 빠른 시간 내에 나타났음을 보
여준다. 동일한 실험을 고장액에서 하였을 때, 역시 증가되는 양상
을 보였다.
또한, calsium 을 매개로한 신호 전달체계를 확인하기 위하여, 
Ca2+의 대표적인 agonist인 carbacol로 자극한 후 insulin에 의한 세포
내부 Ca2+ 변화를 관찰할 수 없었다. 따라서 인슐린에 의한 반응이 
Ca2+을 매개로 한 intracellular signaling pathway를 거치는 것 같지는 
않다. 결론적으로 insulin이 renal tubular cell line인 HEK293 세포에서 
NKCC2 activity를 증가시키는 것으로 보이며, 특히 고장액에서 
NKCC2 mRNA 발현을 증가시켰다. 
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